17.48 USD
+0.04 (+0.23%)
17.48 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 82% to SHC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 19.31. This target is 10.45% above the current price.
SHC was analyzed by 12 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about SHC.
In the previous month the buy percentage consensus was at a similar level.
SHC was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-13 | BMO Capital | Initiate | Outperform |
| 2025-11-05 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-05 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-05 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-10-02 | Barclays | Maintains | Overweight -> Overweight |
| 2025-06-24 | Barclays | Maintains | Overweight -> Overweight |
| 2025-05-05 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2025-04-23 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-04-10 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-28 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-18 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-21 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-06 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-06 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-06 | Barclays | Maintains | Overweight -> Overweight |
| 2024-05-21 | Piper Sandler | Initiate | Neutral |
| 2024-04-10 | Barclays | Maintains | Overweight -> Overweight |
| 2024-04-03 | Citigroup | Upgrade | Neutral -> Buy |
| 2024-03-25 | Jefferies | Upgrade | Hold -> Buy |
| 2024-03-11 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-04 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-02-28 | Barclays | Maintains | Overweight -> Overweight |
| 2024-02-06 | Keybanc | Initiate | Sector Weight |
| 2024-01-25 | Barclays | Maintains | Overweight -> Overweight |
| 2023-11-02 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-11-02 | Barclays | Maintains | Overweight -> Overweight |
| 2023-08-04 | Keybanc | Maintains | Overweight -> Overweight |
| 2023-08-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-06-26 | Keybanc | Upgrade | Sector Weight -> Overweight |
| 2023-06-22 | Keybanc | Maintains | Sector Weight |
SOTERA HEALTH CO / SHC FAQ
What is the price target for SHC stock?
12 analysts have analysed SHC and the average price target is 19.31 USD. This implies a price increase of 10.45% is expected in the next year compared to the current price of 17.48.
Can you provide the consensus rating for SOTERA HEALTH CO stock?
The consensus rating for SOTERA HEALTH CO (SHC) is 81.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.